An Australian-first study demonstrating the effectiveness of a new immunization against respiratory syncytial virus (RSV) for ...

RSV is a virus that infects the nose, throat, and lungs and is often difficult to distinguish from other respiratory viruses, according to the Centers for Disease Control and Prevention.

Historically, RSV has been studied mainly in infants and older adults, but recent research shows that it also poses a ...

With the RSV season officially underway in South Africa, experts are urging healthcare providers to prepare for an influx of ...

The bivalent respiratory syncytial virus prefusion F vaccine is highly effective and well tolerated against RSV-associated ...

Higher hospitalization rates were associated with several chronic conditions, possibly due to a higher likelihood of infection and increased severity of RSV disease. Blood cancer was the chronic ...

In primary care settings, the burden of RSV on young children and their guardians often varied between the countries of ...

South Shore Health infectious disease expert Dr. Todd Ellerin reflected on his personal experience with COVID-19, five years after the World Health Organization declared it a pandemic.